Vecuronium Intubation Dose
For endotracheal intubation, administer vecuronium 0.1 mg/kg IV for routine paralysis or 0.2 mg/kg IV for intubation in pediatric patients, and 0.08-0.1 mg/kg IV in adults. 1
Pediatric Dosing
Standard intubation dose: 0.2 mg/kg IV 1
- Routine paralysis: 0.1 mg/kg IV 1
- Onset: Adequate relaxation occurs in approximately 2 minutes (slower than rocuronium or succinylcholine) 1
- Duration: 45-90 minutes (dose-dependent) 1
Age-Specific Considerations
- Infants <1 year (but >7 weeks): More sensitive to vecuronium on mg/kg basis; recovery takes approximately 1.5 times longer than adults 2
- Children 1-10 years: May require slightly higher initial doses and more frequent supplementation than adults 2
- Children 10-16 years: Same dosage requirements as adults 2
- Infants <7 weeks: Insufficient safety data; use not recommended 2
Important: Research shows the ED95 varies significantly by age—47 mcg/kg in neonates/infants versus 81 mcg/kg in children 3-10 years 3. This explains why younger children may need higher doses despite being more sensitive to the drug's effects.
Adult Dosing
Standard intubation dose: 0.08-0.1 mg/kg IV 4
- Onset: Blockade within 60-90 seconds 4
- Duration: 25-30 minutes 4
- Higher doses: 0.15-0.28 mg/kg have been used safely under halothane anesthesia when cardiovascular stability is maintained 2
Continuous Infusion (Adults)
After intubating dose of 80-100 mcg/kg 2:
- Initial rate: 1 mcg/kg/min (or 0.8-1.2 mcg/kg/min range)
- Start infusion 20-40 minutes after bolus dose
- Adjust based on peripheral nerve stimulation monitoring
- With volatile anesthetics: Reduce rate by 25-60% with enflurane/isoflurane after 45-60 minutes 2
Dose Adjustments in Organ Impairment
Hepatic Impairment
Do not reduce the initial intubating dose in hepatic failure 5
- The initial dose should remain standard because increased volume of distribution in cirrhosis requires normal concentrations for effective intubation 5
- Caution: Duration of action is prolonged with repeated doses due to 50% biliary excretion 4
- Maintenance dosing: Reduce frequency and amount of subsequent doses 4
- Research demonstrates vecuronium 0.15 mg/kg has similar duration in cirrhotic and healthy patients, but 0.2 mg/kg has significantly longer action in cirrhosis 6
- Monitoring essential: Neuromuscular function monitoring is strongly recommended in hepatic dysfunction 6
Renal Impairment
Do not reduce the initial intubating dose in renal failure 5
- Standard intubating doses produce similar ED50, ED90, and ED95 values in renal failure versus normal patients 7
- Caution: Up to 35% renal excretion means prolonged duration with repeated dosing 4
- Maintenance dosing: Decrease requirements for sustained blockade 4
- Recovery after neostigmine is rapid and not associated with recurarization in renal failure 7
Critical Safety Considerations
Mandatory Requirements
Vecuronium provides NO sedation, analgesia, or amnesia 1
- Ventilatory support is mandatory 1
- Personnel skilled in airway management must be present 1
- Age-appropriate equipment for suctioning, oxygenation, intubation, and ventilation must be immediately available 1
Common Pitfalls
Slower onset than alternatives: Vecuronium takes 2 minutes for adequate intubation conditions, making rocuronium or succinylcholine preferred for rapid-sequence intubation in emergencies 1
IV line compatibility: Flush with saline before administration to avoid precipitation when used with thiopental or other alkaline solutions 1, 2
Drug interactions:
Defasciculation dosing: When using succinylcholine in patients with increased ICP, consider 0.01 mg/kg vecuronium as defasciculation dose 1
Neonatal precautions: Avoid bacteriostatic water containing benzyl alcohol in newborns 2